Microvascular changes and microvascular reactivity in stable patients with Chronic Obstructive Pulmonary Disease using non-invasive retinal imaging - Retinal imaging in COPD

Ciro+0 个研究点目标入组 250 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•- COPD as a primary diagnosis according to the Global Initiative For Chronic Obstructive Pulmonary Lung Disease (GOLD) definition: *Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease with some significant extrapulmonary effects that may contribute to the severity in individual patients. Its pulmonary component is characterized by airflow limitation that is not fully reversible. The airflow limitation is usually progressive and associated with an abnormal inflammatory response of the lung to noxious particles or gases*. COPD is diagnosed by a chest physician.
•- Clinically stable on the basis of clinical picture by chest physician .
•- Treated according to the current international guidelines.
•- Permission for voluntary participation. Patients will be asked during baseline assessment and have to sign an informed consent. Patients have the right to withdraw from the study without any negative consequences on their rehabilitation.
•-Attending the regular rehabilitation program in Ciro+ (study part 2)

•- Lack of motivation for voluntary participation in this study.
•- The presence of abnormalities in the lens (e.g. cataract) or retina (e.g. retinal detachment), which makes it impossible to make an image of the retina.
•- The presence of severe retinopathy, which makes it impossible to analyze the microvasculature of the retina.

发起方

Ciro+